Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Engineered T Cells Sales Market Report 2018

  • QYR2451125
  • 115 Pages
  • February 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the global Engineered T Cells market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Engineered T Cells for these regions, from 2013 to 2025 (forecast), covering

United States

China

Europe

Japan

Southeast Asia

India

Global Engineered T Cells market competition by top manufacturers/players, with Engineered T Cells sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

Autolus Limited

Bellicum Pharmaceuticals

Cells Medica

Elli Lilly and Company

Gilead Sciences

Juno Therapeutics

Novartis

Oxford Biomedica

Pfizer

Precision Bioscience

Redmile Group

Seeking Alpha

Unum Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Tumor Infiltrating Lymphocytes

T Cell Receptor {TCR}

Chimeric Antigen Receptor (CAR)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals

Cancer Research Centers

Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Engineered T Cells Sales Market Report 2018

1 Engineered T Cells Market Overview

1.1 Product Overview and Scope of Engineered T Cells

1.2 Classification of Engineered T Cells by Product Category

1.2.1 Global Engineered T Cells Market Size (Sales) Comparison by Type (2013-2025)

1.2.2 Global Engineered T Cells Market Size (Sales) Market Share by Type (Product Category) in 2017

1.2.3 Tumor Infiltrating Lymphocytes

1.2.4 T Cell Receptor {TCR}

1.2.5 Chimeric Antigen Receptor (CAR)

1.3 Global Engineered T Cells Market by Application/End Users

1.3.1 Global Engineered T Cells Sales (Volume) and Market Share Comparison by Application (2013-2025)

1.3.2 Hospitals

1.3.3 Cancer Research Centers

1.3.4 Clinics

1.4 Global Engineered T Cells Market by Region

1.4.1 Global Engineered T Cells Market Size (Value) Comparison by Region (2013-2025)

1.4.2 United States Engineered T Cells Status and Prospect (2013-2025)

1.4.3 China Engineered T Cells Status and Prospect (2013-2025)

1.4.4 Europe Engineered T Cells Status and Prospect (2013-2025)

1.4.5 Japan Engineered T Cells Status and Prospect (2013-2025)

1.4.6 Southeast Asia Engineered T Cells Status and Prospect (2013-2025)

1.4.7 India Engineered T Cells Status and Prospect (2013-2025)

1.5 Global Market Size (Value and Volume) of Engineered T Cells (2013-2025)

1.5.1 Global Engineered T Cells Sales and Growth Rate (2013-2025)

1.5.2 Global Engineered T Cells Revenue and Growth Rate (2013-2025)

2 Global Engineered T Cells Competition by Players/Suppliers, Type and Application

2.1 Global Engineered T Cells Market Competition by Players/Suppliers

2.1.1 Global Engineered T Cells Sales and Market Share of Key Players/Suppliers (2013-2018)

2.1.2 Global Engineered T Cells Revenue and Share by Players/Suppliers (2013-2018)

2.2 Global Engineered T Cells (Volume and Value) by Type

2.2.1 Global Engineered T Cells Sales and Market Share by Type (2013-2018)

2.2.2 Global Engineered T Cells Revenue and Market Share by Type (2013-2018)

2.3 Global Engineered T Cells (Volume and Value) by Region

2.3.1 Global Engineered T Cells Sales and Market Share by Region (2013-2018)

2.3.2 Global Engineered T Cells Revenue and Market Share by Region (2013-2018)

2.4 Global Engineered T Cells (Volume) by Application

3 United States Engineered T Cells (Volume, Value and Sales Price)

3.1 United States Engineered T Cells Sales and Value (2013-2018)

3.1.1 United States Engineered T Cells Sales and Growth Rate (2013-2018)

3.1.2 United States Engineered T Cells Revenue and Growth Rate (2013-2018)

3.1.3 United States Engineered T Cells Sales Price Trend (2013-2018)

3.2 United States Engineered T Cells Sales Volume and Market Share by Players (2013-2018)

3.3 United States Engineered T Cells Sales Volume and Market Share by Type (2013-2018)

3.4 United States Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

4 China Engineered T Cells (Volume, Value and Sales Price)

4.1 China Engineered T Cells Sales and Value (2013-2018)

4.1.1 China Engineered T Cells Sales and Growth Rate (2013-2018)

4.1.2 China Engineered T Cells Revenue and Growth Rate (2013-2018)

4.1.3 China Engineered T Cells Sales Price Trend (2013-2018)

4.2 China Engineered T Cells Sales Volume and Market Share by Players (2013-2018)

4.3 China Engineered T Cells Sales Volume and Market Share by Type (2013-2018)

4.4 China Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

5 Europe Engineered T Cells (Volume, Value and Sales Price)

5.1 Europe Engineered T Cells Sales and Value (2013-2018)

5.1.1 Europe Engineered T Cells Sales and Growth Rate (2013-2018)

5.1.2 Europe Engineered T Cells Revenue and Growth Rate (2013-2018)

5.1.3 Europe Engineered T Cells Sales Price Trend (2013-2018)

5.2 Europe Engineered T Cells Sales Volume and Market Share by Players (2013-2018)

5.3 Europe Engineered T Cells Sales Volume and Market Share by Type (2013-2018)

5.4 Europe Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

6 Japan Engineered T Cells (Volume, Value and Sales Price)

6.1 Japan Engineered T Cells Sales and Value (2013-2018)

6.1.1 Japan Engineered T Cells Sales and Growth Rate (2013-2018)

6.1.2 Japan Engineered T Cells Revenue and Growth Rate (2013-2018)

6.1.3 Japan Engineered T Cells Sales Price Trend (2013-2018)

6.2 Japan Engineered T Cells Sales Volume and Market Share by Players (2013-2018)

6.3 Japan Engineered T Cells Sales Volume and Market Share by Type (2013-2018)

6.4 Japan Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Engineered T Cells (Volume, Value and Sales Price)

7.1 Southeast Asia Engineered T Cells Sales and Value (2013-2018)

7.1.1 Southeast Asia Engineered T Cells Sales and Growth Rate (2013-2018)

7.1.2 Southeast Asia Engineered T Cells Revenue and Growth Rate (2013-2018)

7.1.3 Southeast Asia Engineered T Cells Sales Price Trend (2013-2018)

7.2 Southeast Asia Engineered T Cells Sales Volume and Market Share by Players (2013-2018)

7.3 Southeast Asia Engineered T Cells Sales Volume and Market Share by Type (2013-2018)

7.4 Southeast Asia Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

8 India Engineered T Cells (Volume, Value and Sales Price)

8.1 India Engineered T Cells Sales and Value (2013-2018)

8.1.1 India Engineered T Cells Sales and Growth Rate (2013-2018)

8.1.2 India Engineered T Cells Revenue and Growth Rate (2013-2018)

8.1.3 India Engineered T Cells Sales Price Trend (2013-2018)

8.2 India Engineered T Cells Sales Volume and Market Share by Players (2013-2018)

8.3 India Engineered T Cells Sales Volume and Market Share by Type (2013-2018)

8.4 India Engineered T Cells Sales Volume and Market Share by Application (2013-2018)

9 Global Engineered T Cells Players/Suppliers Profiles and Sales Data

9.1 Autolus Limited

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Engineered T Cells Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Autolus Limited Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.1.4 Main Business/Business Overview

9.2 Bellicum Pharmaceuticals

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Engineered T Cells Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.2.4 Main Business/Business Overview

9.3 Cells Medica

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Engineered T Cells Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Cells Medica Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.3.4 Main Business/Business Overview

9.4 Elli Lilly and Company

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Engineered T Cells Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.4.4 Main Business/Business Overview

9.5 Gilead Sciences

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Engineered T Cells Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Gilead Sciences Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.5.4 Main Business/Business Overview

9.6 Juno Therapeutics

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Engineered T Cells Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.6.4 Main Business/Business Overview

9.7 Novartis

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Engineered T Cells Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Novartis Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.7.4 Main Business/Business Overview

9.8 Oxford Biomedica

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Engineered T Cells Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.8.4 Main Business/Business Overview

9.9 Pfizer

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Engineered T Cells Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Pfizer Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.9.4 Main Business/Business Overview

9.10 Precision Bioscience

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Engineered T Cells Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Precision Bioscience Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)

9.10.4 Main Business/Business Overview

9.11 Redmile Group

9.12 Seeking Alpha

9.13 Unum Therapeutics

10 Engineered T Cells Maufacturing Cost Analysis

10.1 Engineered T Cells Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Engineered T Cells

10.3 Manufacturing Process Analysis of Engineered T Cells

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Engineered T Cells Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Engineered T Cells Major Manufacturers in 2017

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Engineered T Cells Market Forecast (2018-2025)

14.1 Global Engineered T Cells Sales Volume, Revenue and Price Forecast (2018-2025)

14.1.1 Global Engineered T Cells Sales Volume and Growth Rate Forecast (2018-2025)

14.1.2 Global Engineered T Cells Revenue and Growth Rate Forecast (2018-2025)

14.1.3 Global Engineered T Cells Price and Trend Forecast (2018-2025)

14.2 Global Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)

14.2.1 Global Engineered T Cells Sales Volume and Growth Rate Forecast by Regions (2018-2025)

14.2.2 Global Engineered T Cells Revenue and Growth Rate Forecast by Regions (2018-2025)

14.2.3 United States Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.4 China Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.5 Europe Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.6 Japan Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.7 Southeast Asia Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.8 India Engineered T Cells Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.3 Global Engineered T Cells Sales Volume, Revenue and Price Forecast by Type (2018-2025)

14.3.1 Global Engineered T Cells Sales Forecast by Type (2018-2025)

14.3.2 Global Engineered T Cells Revenue Forecast by Type (2018-2025)

14.3.3 Global Engineered T Cells Price Forecast by Type (2018-2025)

14.4 Global Engineered T Cells Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Engineered T Cells

Figure Global Engineered T Cells Sales Volume Comparison (K Units) by Type (2013-2025)

Figure Global Engineered T Cells Sales Volume Market Share by Type (Product Category) in 2017

Figure Tumor Infiltrating Lymphocytes Product Picture

Figure T Cell Receptor {TCR} Product Picture

Figure Chimeric Antigen Receptor (CAR) Product Picture

Figure Global Engineered T Cells Sales Comparison (K Units) by Application (2013-2025)

Figure Global Sales Market Share of Engineered T Cells by Application in 2017

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Cancer Research Centers Examples

Table Key Downstream Customer in Cancer Research Centers

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Global Engineered T Cells Market Size (Million USD) by Regions (2013-2025)

Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure China Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure Japan Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southeast Asia Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure India Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Engineered T Cells Sales Volume (K Units) and Growth Rate (2013-2025)

Figure Global Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Market Major Players Engineered T Cells Sales Volume (K Units) (2013-2018)

Table Global Engineered T Cells Sales (K Units) of Key Players/Suppliers (2013-2018)

Table Global Engineered T Cells Sales Share by Players/Suppliers (2013-2018)

Figure 2017 Engineered T Cells Sales Share by Players/Suppliers

Figure 2017 Engineered T Cells Sales Share by Players/Suppliers

Figure Global Engineered T Cells Revenue (Million USD) by Players/Suppliers (2013-2018)

Table Global Engineered T Cells Revenue (Million USD) by Players/Suppliers (2013-2018)

Table Global Engineered T Cells Revenue Share by Players/Suppliers (2013-2018)

Table 2017 Global Engineered T Cells Revenue Share by Players

Table 2017 Global Engineered T Cells Revenue Share by Players

Table Global Engineered T Cells Sales (K Units) and Market Share by Type (2013-2018)

Table Global Engineered T Cells Sales Share (K Units) by Type (2013-2018)

Figure Sales Market Share of Engineered T Cells by Type (2013-2018)

Figure Global Engineered T Cells Sales Growth Rate by Type (2013-2018)

Table Global Engineered T Cells Revenue (Million USD) and Market Share by Type (2013-2018)

Table Global Engineered T Cells Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Engineered T Cells by Type (2013-2018)

Figure Global Engineered T Cells Revenue Growth Rate by Type (2013-2018)

Table Global Engineered T Cells Sales Volume (K Units) and Market Share by Region (2013-2018)

Table Global Engineered T Cells Sales Share by Region (2013-2018)

Figure Sales Market Share of Engineered T Cells by Region (2013-2018)

Figure Global Engineered T Cells Sales Growth Rate by Region in 2017

Table Global Engineered T Cells Revenue (Million USD) and Market Share by Region (2013-2018)

Table Global Engineered T Cells Revenue Share (%) by Region (2013-2018)

Figure Revenue Market Share of Engineered T Cells by Region (2013-2018)

Figure Global Engineered T Cells Revenue Growth Rate by Region in 2017

Table Global Engineered T Cells Revenue (Million USD) and Market Share by Region (2013-2018)

Table Global Engineered T Cells Revenue Share (%) by Region (2013-2018)

Figure Revenue Market Share of Engineered T Cells by Region (2013-2018)

Figure Global Engineered T Cells Revenue Market Share by Region in 2017

Table Global Engineered T Cells Sales Volume (K Units) and Market Share by Application (2013-2018)

Table Global Engineered T Cells Sales Share (%) by Application (2013-2018)

Figure Sales Market Share of Engineered T Cells by Application (2013-2018)

Figure Global Engineered T Cells Sales Market Share by Application (2013-2018)

Figure United States Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)

Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)

Figure United States Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)

Table United States Engineered T Cells Sales Volume (K Units) by Players (2013-2018)

Table United States Engineered T Cells Sales Volume Market Share by Players (2013-2018)

Figure United States Engineered T Cells Sales Volume Market Share by Players in 2017

Table United States Engineered T Cells Sales Volume (K Units) by Type (2013-2018)

Table United States Engineered T Cells Sales Volume Market Share by Type (2013-2018)

Figure United States Engineered T Cells Sales Volume Market Share by Type in 2017

Table United States Engineered T Cells Sales Volume (K Units) by Application (2013-2018)

Table United States Engineered T Cells Sales Volume Market Share by Application (2013-2018)

Figure United States Engineered T Cells Sales Volume Market Share by Application in 2017

Figure China Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)

Figure China Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)

Figure China Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)

Table China Engineered T Cells Sales Volume (K Units) by Players (2013-2018)

Table China Engineered T Cells Sales Volume Market Share by Players (2013-2018)

Figure China Engineered T Cells Sales Volume Market Share by Players in 2017

Table China Engineered T Cells Sales Volume (K Units) by Type (2013-2018)

Table China Engineered T Cells Sales Volume Market Share by Type (2013-2018)

Figure China Engineered T Cells Sales Volume Market Share by Type in 2017

Table China Engineered T Cells Sales Volume (K Units) by Application (2013-2018)

Table China Engineered T Cells Sales Volume Market Share by Application (2013-2018)

Figure China Engineered T Cells Sales Volume Market Share by Application in 2017

Figure Europe Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)

Figure Europe Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)

Figure Europe Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)

Table Europe Engineered T Cells Sales Volume (K Units) by Players (2013-2018)

Table Europe Engineered T Cells Sales Volume Market Share by Players (2013-2018)

Figure Europe Engineered T Cells Sales Volume Market Share by Players in 2017

Table Europe Engineered T Cells Sales Volume (K Units) by Type (2013-2018)

Table Europe Engineered T Cells Sales Volume Market Share by Type (2013-2018)

Figure Europe Engineered T Cells Sales Volume Market Share by Type in 2017

Table Europe Engineered T Cells Sales Volume (K Units) by Application (2013-2018)

Table Europe Engineered T Cells Sales Volume Market Share by Application (2013-2018)

Figure Europe Engineered T Cells Sales Volume Market Share by Application in 2017

Figure Japan Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)

Figure Japan Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)

Figure Japan Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)

Table Japan Engineered T Cells Sales Volume (K Units) by Players (2013-2018)

Table Japan Engineered T Cells Sales Volume Market Share by Players (2013-2018)

Figure Japan Engineered T Cells Sales Volume Market Share by Players in 2017

Table Japan Engineered T Cells Sales Volume (K Units) by Type (2013-2018)

Table Japan Engineered T Cells Sales Volume Market Share by Type (2013-2018)

Figure Japan Engineered T Cells Sales Volume Market Share by Type in 2017

Table Japan Engineered T Cells Sales Volume (K Units) by Application (2013-2018)

Table Japan Engineered T Cells Sales Volume Market Share by Application (2013-2018)

Figure Japan Engineered T Cells Sales Volume Market Share by Application in 2017

Figure Southeast Asia Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)

Figure Southeast Asia Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)

Figure Southeast Asia Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)

Table Southeast Asia Engineered T Cells Sales Volume (K Units) by Players (2013-2018)

Table Southeast Asia Engineered T Cells Sales Volume Market Share by Players (2013-2018)

Figure Southeast Asia Engineered T Cells Sales Volume Market Share by Players in 2017

Table Southeast Asia Engineered T Cells Sales Volume (K Units) by Type (2013-2018)

Table Southeast Asia Engineered T Cells Sales Volume Market Share by Type (2013-2018)

Figure Southeast Asia Engineered T Cells Sales Volume Market Share by Type in 2017

Table Southeast Asia Engineered T Cells Sales Volume (K Units) by Application (2013-2018)

Table Southeast Asia Engineered T Cells Sales Volume Market Share by Application (2013-2018)

Figure Southeast Asia Engineered T Cells Sales Volume Market Share by Application in 2017

Figure India Engineered T Cells Sales (K Units) and Growth Rate (2013-2018)

Figure India Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2018)

Figure India Engineered T Cells Sales Price (USD/Unit) Trend (2013-2018)

Table India Engineered T Cells Sales Volume (K Units) by Players (2013-2018)

Table India Engineered T Cells Sales Volume Market Share by Players (2013-2018)

Figure India Engineered T Cells Sales Volume Market Share by Players in 2017

Table India Engineered T Cells Sales Volume (K Units) by Type (2013-2018)

Table India Engineered T Cells Sales Volume Market Share by Type (2013-2018)

Figure India Engineered T Cells Sales Volume Market Share by Type in 2017

Table India Engineered T Cells Sales Volume (K Units) by Application (2013-2018)

Table India Engineered T Cells Sales Volume Market Share by Application (2013-2018)

Figure India Engineered T Cells Sales Volume Market Share by Application in 2017

Table Autolus Limited Basic Information List

Table Autolus Limited Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Autolus Limited Engineered T Cells Sales Growth Rate (2013-2018)

Figure Autolus Limited Engineered T Cells Sales Global Market Share (2013-2018)

Figure Autolus Limited Engineered T Cells Revenue Global Market Share (2013-2018)

Table Bellicum Pharmaceuticals Basic Information List

Table Bellicum Pharmaceuticals Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Bellicum Pharmaceuticals Engineered T Cells Sales Growth Rate (2013-2018)

Figure Bellicum Pharmaceuticals Engineered T Cells Sales Global Market Share (2013-2018)

Figure Bellicum Pharmaceuticals Engineered T Cells Revenue Global Market Share (2013-2018)

Table Cells Medica Basic Information List

Table Cells Medica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Cells Medica Engineered T Cells Sales Growth Rate (2013-2018)

Figure Cells Medica Engineered T Cells Sales Global Market Share (2013-2018

Figure Cells Medica Engineered T Cells Revenue Global Market Share (2013-2018)

Table Elli Lilly and Company Basic Information List

Table Elli Lilly and Company Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Elli Lilly and Company Engineered T Cells Sales Growth Rate (2013-2018)

Figure Elli Lilly and Company Engineered T Cells Sales Global Market Share (2013-2018)

Figure Elli Lilly and Company Engineered T Cells Revenue Global Market Share (2013-2018)

Table Gilead Sciences Basic Information List

Table Gilead Sciences Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Gilead Sciences Engineered T Cells Sales Growth Rate (2013-2018)

Figure Gilead Sciences Engineered T Cells Sales Global Market Share (2013-2018)

Figure Gilead Sciences Engineered T Cells Revenue Global Market Share (2013-2018)

Table Juno Therapeutics Basic Information List

Table Juno Therapeutics Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Juno Therapeutics Engineered T Cells Sales Growth Rate (2013-2018)

Figure Juno Therapeutics Engineered T Cells Sales Global Market Share (2013-2018

Figure Juno Therapeutics Engineered T Cells Revenue Global Market Share (2013-2018)

Table Novartis Basic Information List

Table Novartis Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Novartis Engineered T Cells Sales Growth Rate (2013-2018)

Figure Novartis Engineered T Cells Sales Global Market Share (2013-2018)

Figure Novartis Engineered T Cells Revenue Global Market Share (2013-2018)

Table Oxford Biomedica Basic Information List

Table Oxford Biomedica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Oxford Biomedica Engineered T Cells Sales Growth Rate (2013-2018)

Figure Oxford Biomedica Engineered T Cells Sales Global Market Share (2013-2018

Figure Oxford Biomedica Engineered T Cells Revenue Global Market Share (2013-2018)

Table Pfizer Basic Information List

Table Pfizer Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer Engineered T Cells Sales Growth Rate (2013-2018)

Figure Pfizer Engineered T Cells Sales Global Market Share (2013-2018)

Figure Pfizer Engineered T Cells Revenue Global Market Share (2013-2018)

Table Precision Bioscience Basic Information List

Table Precision Bioscience Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Precision Bioscience Engineered T Cells Sales Growth Rate (2013-2018)

Figure Precision Bioscience Engineered T Cells Sales Global Market Share (2013-2018)

Figure Precision Bioscience Engineered T Cells Revenue Global Market Share (2013-2018)

Table Redmile Group Basic Information List

Table Seeking Alpha Basic Information List

Table Unum Therapeutics Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Engineered T Cells

Figure Manufacturing Process Analysis of Engineered T Cells

Figure Engineered T Cells Industrial Chain Analysis

Table Raw Materials Sources of Engineered T Cells Major Players in 2017

Table Major Buyers of Engineered T Cells

Table Distributors/Traders List

Figure Global Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Global Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Global Engineered T Cells Price (USD/Unit) and Trend Forecast (2018-2025)

Table Global Engineered T Cells Sales Volume (K Units) Forecast by Regions (2018-2025)

Figure Global Engineered T Cells Sales Volume Market Share Forecast by Regions (2018-2025)

Figure Global Engineered T Cells Sales Volume Market Share Forecast by Regions in 2025

Table Global Engineered T Cells Revenue (Million USD) Forecast by Regions (2018-2025)

Figure Global Engineered T Cells Revenue Market Share Forecast by Regions (2018-2025)

Figure Global Engineered T Cells Revenue Market Share Forecast by Regions in 2025

Figure United States Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure China Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure China Engineered T Cells Revenue and Growth Rate Forecast (2018-2025)

Figure Europe Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Europe Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Japan Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Japan Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure India Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure India Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Global Engineered T Cells Sales (K Units) Forecast by Type (2018-2025)

Figure Global Engineered T Cells Sales Volume Market Share Forecast by Type (2018-2025)

Table Global Engineered T Cells Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global Engineered T Cells Revenue Market Share Forecast by Type (2018-2025)

Table Global Engineered T Cells Price (USD/Unit) Forecast by Type (2018-2025)

Table Global Engineered T Cells Sales (K Units) Forecast by Application (2018-2025)

Figure Global Engineered T Cells Sales Market Share Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370